Related Experiment Videos
Relationship Between Clinical Manifestations of Acute Rheumatic Fever and Mutations in the FMF-Associated MEFV Gene
Mustafa Dogan1, Metin Tan2, Emre Tepeli3
1Department of Pediatric Cardiology, Faculty of Medicine, Kocaeli University, Kocaeli 41380, Turkey.
Insights
This study investigated Familial Mediterranean fever (FMF) gene mutations in children with acute rheumatic fever (ARF). A specific FMF gene mutation in exon 2 was more common in ARF patients, suggesting a potential link.
Area of Science:
- Pediatric Rheumatology
- Genetic Medicine
- Molecular Biology
Background:
- Acute rheumatic fever (ARF) presents with diverse symptoms including arthritis and carditis, with prognosis linked to carditis severity.
- The exact pathophysiology of ARF, particularly factors influencing carditis, arthritis, or chorea development, remains incompletely understood.
- Familial Mediterranean fever (FMF), a common rheumatic disease with well-defined pathophysiology in the Turkish population, has a high carrier rate for FMF gene mutations.
Purpose of the Study:
- To explore the correlation between Familial Mediterranean fever (FMF) gene mutations and the clinical presentation of acute rheumatic fever (ARF) in pediatric patients.
- To investigate the prevalence of specific FMF gene mutations (exons 2 and 10 of the MEFV gene) in children diagnosed with ARF.
- To determine if FMF gene mutations are associated with the development of arthritis, carditis, or both in ARF patients.
Main Methods:
- A case-control study involving 60 pediatric patients with ARF (manifesting as arthritis, carditis, or both) and 60 healthy controls.
- Genetic screening of the MEFV gene, focusing on mutations in exon 2 and exon 10, was performed on all participants.
- Statistical analysis was used to compare the incidence of MEFV gene mutations between the ARF patient group and the control group.
Main Results:
- No significant difference in the incidence of MEFV gene mutations in exon 10 was observed between ARF patients and healthy controls.
- The E148Q variant in exon 2 of the MEFV gene was found to be significantly more prevalent in pediatric patients with ARF compared to the control group.
- These findings indicate a potential association between specific MEFV gene variants and the occurrence of ARF.
Conclusions:
- The study suggests a potential relationship between certain clinical manifestations of acute rheumatic fever (ARF) and the presence of Familial Mediterranean fever (FMF) gene mutations in children.
- Specifically, the exon 2 E148Q variant of the MEFV gene may play a role in the development or presentation of ARF.
- Further research is warranted to elucidate the precise mechanisms underlying this observed association.
Abstract:
Background/Objectives: In individuals with a genetic predisposition, acute rheumatic fever (ARF) can manifest as arthritis, carditis, chorea, subcutaneous nodules, and erythema marginatum. It occurs after a latent period of 1-3 weeks of untreated upper respiratory tract infections caused by group A beta-hemolytic streptococci. The presence and severity of carditis determine the prognosis for ARF. Carditis manifests as pancarditis, and although all patients have pericarditis, not all experience a pericardial effusion. Patients with severe carditis exhibit pericardial effusion more frequently. The physiopathology of ARF remains unclear, specifically which patients will experience carditis, arthritis, or chorea. However, the Turkish population has fully clarified the physiopathology and clinical features of Familial Mediterranean fever (FMF), a common rheumatic disease. In the Turkish population, the heterozygous positivity rate for the FMF gene mutation is 15-35%. For these reasons, we examined the presence of FMF gene mutations in our patients to determine whether there is a correlation between the clinical course of ARF and the FMF gene mutation. Methods: The study included 60 patients with arthritis (n = 11), carditis (n = 26), or both (n = 23), as well as 60 healthy controls. These pediatric patients underwent screening for mutations in exons 2 and 10 of the MEFV gene. Results: There was no statistically significant difference between the patient and control groups in terms of the incidence of MEFV gene mutations in exon 10. However, in patients with ARF, the exon 2 E148Q variant was significantly more common than in the control group. Conclusions: This study suggests a relationship between certain clinical manifestations of ARF and MEFV gene mutations in children.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Rocky Mountain Spotted Fever
Myocarditis III: Medical Management
Rheumatic Heart Disease III: Medical Management